Graybug Vision (GRAY) Competitors $3.20 +0.09 (+2.73%) As of 09/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock GRAY vs. TAOX, IBIO, ETHZ, NBY, AEON, MTNB, OBSV, CPHI, NRBO, and SPRBShould you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include Synaptogenix (TAOX), iBio (IBIO), Flag Ship Acquisition (ETHZ), NovaBay Pharmaceuticals (NBY), AEON Biopharma (AEON), Matinas Biopharma (MTNB), ObsEva (OBSV), China Pharma (CPHI), NeuroBo Pharmaceuticals (NRBO), and Spruce Biosciences (SPRB). Graybug Vision vs. Its Competitors Synaptogenix iBio Flag Ship Acquisition NovaBay Pharmaceuticals AEON Biopharma Matinas Biopharma ObsEva China Pharma NeuroBo Pharmaceuticals Spruce Biosciences Synaptogenix (NASDAQ:TAOX) and Graybug Vision (NASDAQ:GRAY) are both small-cap pharmaceutical preparations industry companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Does the media favor TAOX or GRAY? In the previous week, Synaptogenix's average media sentiment score of 1.91 beat Graybug Vision's score of 0.00 indicating that Synaptogenix is being referred to more favorably in the media. Company Overall Sentiment Synaptogenix Very Positive Graybug Vision Neutral Which has better valuation & earnings, TAOX or GRAY? Synaptogenix is trading at a lower price-to-earnings ratio than Graybug Vision, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynaptogenixN/AN/A-$12.77M-$20.16-0.31Graybug VisionN/AN/A-$35.60M-$24.23-0.13 Do institutionals & insiders hold more shares of TAOX or GRAY? 10.3% of Synaptogenix shares are owned by institutional investors. Comparatively, 49.9% of Graybug Vision shares are owned by institutional investors. 2.7% of Synaptogenix shares are owned by insiders. Comparatively, 7.9% of Graybug Vision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is TAOX or GRAY more profitable? Graybug Vision's return on equity of -77.61% beat Synaptogenix's return on equity.Company Net Margins Return on Equity Return on Assets SynaptogenixN/A -277.76% -150.79% Graybug Vision N/A -77.61%-71.34% Which has more risk and volatility, TAOX or GRAY? Synaptogenix has a beta of 1.87, meaning that its share price is 87% more volatile than the S&P 500. Comparatively, Graybug Vision has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. SummarySynaptogenix beats Graybug Vision on 5 of the 9 factors compared between the two stocks. Get Graybug Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAY vs. The Competition Export to ExcelMetricGraybug VisionPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.03M$857.84M$5.77B$10.29BDividend YieldN/A4.84%5.74%4.60%P/E Ratio-1.851.1457.7723.00Price / SalesN/A26.49538.41125.09Price / CashN/A19.5637.1760.63Price / Book1.926.7013.836.37Net Income-$35.60M-$4.03M$3.29B$271.46M7 Day Performance-8.31%-0.47%0.93%2.35%1 Month Performance9.97%7.67%5.31%7.78%1 Year Performance-18.16%19.24%84.25%32.27% Graybug Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRAYGraybug VisionN/A$3.20+2.7%N/A-23.5%$5.03MN/A-1.8527Gap UpHigh Trading VolumeTAOXSynaptogenix0.1957 of 5 stars$6.27+0.5%N/AN/A$21.88MN/A-0.314Positive NewsIBIOiBio1.6914 of 5 stars$0.86+3.6%$5.00+479.4%-55.4%$16.83M$375K-0.49100ETHZFlag Ship AcquisitionN/A$2.60+6.6%N/AN/A$15.70MN/A-0.177News CoverageNBYNovaBay Pharmaceuticals0.4636 of 5 stars$2.59+12.6%$0.85-67.2%+230.3%$15.08M$9.78M-0.0530News CoverageAEONAEON Biopharma3.3908 of 5 stars$0.73-2.1%$360.00+49,013.2%-98.5%$8.54MN/A4.075Short Interest ↓Gap DownMTNBMatinas Biopharma0.0905 of 5 stars$1.66+1.5%N/AN/A$8.47MN/A-0.3430OBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050CPHIChina Pharma0.3618 of 5 stars$1.91+5.2%N/A-90.6%$6.22M$4.40M0.00250Negative NewsNRBONeuroBo PharmaceuticalsN/A$0.68-1.8%N/A-61.2%$5.84MN/A0.0010SPRBSpruce Biosciences1.4401 of 5 stars$9.86+9.6%$131.25+1,231.1%-71.9%$5.54M$4.91M-10.4920Gap Down Related Companies and Tools Related Companies TAOX Competitors IBIO Competitors ETHZ Competitors NBY Competitors AEON Competitors MTNB Competitors OBSV Competitors CPHI Competitors NRBO Competitors SPRB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAY) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graybug Vision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graybug Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRAY Stock Alerts